Yayın:
Synthesis, In Vitro Anticholinesterase and Antimicrobial Evaluation of New 1,3,4-Thiadiazole-Piperazine Derivatives

dc.contributor.authorUlviye Acar Çevik
dc.contributor.authorULVİYE, ACAR
dc.contributor.authorBegüm Nurpelin Sağlık
dc.contributor.authorSAĞLIK ÖZKAN, BEGÜM NURPELİN
dc.contributor.orcid0000-0003-1879-1034
dc.contributor.orcid0000-0002-0151-6266
dc.date.accessioned2025-11-13T22:36:07Z
dc.date.issued2019-12-20
dc.identifier.doi10.35193/bseufbd.601344
dc.identifier.endpage432
dc.identifier.issn2458-7575
dc.identifier.issue2
dc.identifier.openalexW2994753596
dc.identifier.startpage424
dc.identifier.urihttps://hdl.handle.net/11421/14697
dc.identifier.urihttps://doi.org/10.35193/bseufbd.601344
dc.identifier.volume6
dc.language.isoen
dc.relation.ispartofBilecik Şeyh Edebali Üniversitesi Fen Bilimleri Dergisi
dc.rightsopenAccess
dc.subjectPiperazine
dc.subjectChemistry
dc.subjectAntibacterial activity
dc.subjectAntimicrobial
dc.subjectStereochemistry
dc.subjectEnterococcus faecalis
dc.subjectMinimum inhibitory concentration
dc.subjectCarbon-13 NMR
dc.subjectProton NMR
dc.subjectNuclear chemistry
dc.subjectBacteria
dc.subjectOrganic chemistry
dc.subjectBiochemistry
dc.subjectEscherichia coli
dc.subjectBiology
dc.titleSynthesis, In Vitro Anticholinesterase and Antimicrobial Evaluation of New 1,3,4-Thiadiazole-Piperazine Derivatives
dc.typeArticle
dspace.entity.typePublication
local.authorid.openalexA5047270177
local.authorid.openalexA5074136342

Dosyalar

Koleksiyonlar